Literature DB >> 3131194

Assessment of the lactulose-mannitol test in Crohn's disease.

F Andre1, C Andre, Y Emery, J Forichon, L Descos, Y Minaire.   

Abstract

The mannitol-lactulose intestinal permeability test was evaluated in 100 healthy controls and 47 patients with Crohn's disease. These patients were further separated into three subgroups of increased activity (Harvey-Bradshaw index) and in two subgroups, with elective colonic lesions and associated ileal and colonic lesions. Results were given as percentages of urinary recoveries for mannitol (M), lactulose (L), and L/M ratio. As a whole, patients with Crohn's disease have lower mean M and higher mean L and mean L/M ratios than controls. The magnitude of alterations in M, L, and L/M increased with activity. The sensitivity of the test, however, reached interesting figures (67%:L and 86%:L/M) only in subgroup III which was composed of relapsing patients. Mean M was lower in patients with associated ileal lesion but, whatever the criterion (M, L, or L/M), the test does not provide any clue for the detection of a possible infraclinical associated ileal localisation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3131194      PMCID: PMC1433525          DOI: 10.1136/gut.29.4.511

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  19 in total

1.  Lactulose, 51Cr-labelled ethylenediaminetetra-acetate, L-rhamnose and polyethyleneglycol 400 [corrected] as probe markers for assessment in vivo of human intestinal permeability.

Authors:  D G Maxton; I Bjarnason; A P Reynolds; S D Catt; T J Peters; I S Menzies
Journal:  Clin Sci (Lond)       Date:  1986-07       Impact factor: 6.124

2.  In vitro determination of small intestinal permeability: demonstration of a persistent defect in patients with coeliac disease.

Authors:  I Bjarnason; T J Peters
Journal:  Gut       Date:  1984-02       Impact factor: 23.059

3.  Cellobiose/mannitol sugar permeability test complements biopsy histopathology in clinical investigation of the jejunum.

Authors:  S Strobel; W G Brydon; A Ferguson
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

4.  Altered intestinal permeability to low-molecular-weight polyethyleneglycols (PEG 400) in patients with Crohn's disease.

Authors:  K E Magnusson; T Sundqvist; R Sjödahl; C Tagesson
Journal:  Acta Chir Scand       Date:  1983

5.  Abnormal small intestinal permeability to sugars in patients with Crohn's disease of the terminal ileum and colon.

Authors:  S O Ukabam; J R Clamp; B T Cooper
Journal:  Digestion       Date:  1983       Impact factor: 3.216

6.  A persistent defect in intestinal permeability in coeliac disease demonstrated by a 51Cr-labelled EDTA absorption test.

Authors:  I Bjarnason; T J Peters; N Veall
Journal:  Lancet       Date:  1983-02-12       Impact factor: 79.321

7.  Increased permeability to polyethylene glycol 4000 in rabbits with experimental colitis.

Authors:  E G Seidman; D G Hanson; W A Walker
Journal:  Gastroenterology       Date:  1986-01       Impact factor: 22.682

8.  [Food allergy. Objective diagnosis and test of therapeutic efficacy by measuring intestinal permeability].

Authors:  C André
Journal:  Presse Med       Date:  1986-01-25       Impact factor: 1.228

9.  Intestinal permeability in children with Crohn's disease and coeliac disease.

Authors:  A D Pearson; E J Eastham; M F Laker; A W Craft; R Nelson
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-03

10.  Intestinal permeability in patients with coeliac disease and dermatitis herpetiformis.

Authors:  I Bjarnason; M N Marsh; A Price; A J Levi; T J Peters
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

View more
  18 in total

1.  Intestinal permeability in the critically ill.

Authors:  C E Harris; R D Griffiths; N Freestone; D Billington; S T Atherton; R R Macmillan
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

2.  Enhanced absorption of macromolecules. A secondary factor in Crohn's disease.

Authors:  M Malin; E Isolauri; P Pikkarainen; R Karikoski; J Isolauri
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

Review 3.  The intestinal epithelial barrier: a therapeutic target?

Authors:  Matthew A Odenwald; Jerrold R Turner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-11-16       Impact factor: 46.802

4.  Intestinal permeability in subjects from two different race groups with diverse stone-risk profiles.

Authors:  Takalani Theka; Allen Rodgers; Neil Ravenscroft; Sonja Lewandowski
Journal:  Urolithiasis       Date:  2013-01-22       Impact factor: 3.436

5.  Glutamine and whey protein improve intestinal permeability and morphology in patients with Crohn's disease: a randomized controlled trial.

Authors:  Jaya Benjamin; Govind Makharia; Vineet Ahuja; K D Anand Rajan; Mani Kalaivani; Siddhartha Datta Gupta; Yogendra Kumar Joshi
Journal:  Dig Dis Sci       Date:  2011-10-26       Impact factor: 3.199

6.  Comparison of the permeability characteristics of a human colonic epithelial (Caco-2) cell line to colon of rabbit, monkey, and dog intestine and human drug absorption.

Authors:  W Rubas; N Jezyk; G M Grass
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

7.  Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives.

Authors:  P Munkholm; E Langholz; D Hollander; K Thornberg; M Orholm; K D Katz; V Binder
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

8.  [Intestinal permeability in patients with acquired immunodeficiency syndrome (AIDS)].

Authors:  M Ott; B Lembcke; S Staszewski; E B Helm; W F Caspary
Journal:  Klin Wochenschr       Date:  1991-10-02

9.  Intestinal permeability and its association with the patient and disease characteristics in Crohn's disease.

Authors:  Jaya Benjamin; Govind K Makharia; Vineet Ahuja; Mani Kalaivani; Yogendra K Joshi
Journal:  World J Gastroenterol       Date:  2008-03-07       Impact factor: 5.742

10.  Standardising the lactulose mannitol test of gut permeability to minimise error and promote comparability.

Authors:  Ivana R Sequeira; Roger G Lentle; Marlena C Kruger; Roger D Hurst
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.